SOX9, a highly sensitive and specific marker to discriminate hepatocellular carcinoma from intrahepatic cholangiocarcinoma

被引:0
|
作者
Ding, X. [1 ]
Trac, B. [1 ]
Duan, X. [1 ]
机构
[1] Loyola Univ Med Ctr, Maywood, IL 60153 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
PS-21-004
引用
收藏
页码:S214 / S214
页数:1
相关论文
共 50 条
  • [1] SOX9, a useful Immunohistochemical Marker to Discriminate Hepatocellular Carcinomas from Intrahepatic Cholangiocarcinomas
    Khan, Reema
    Ding, Xianzhong
    Ma, Yihong
    Chen, Hannah
    Pambuccian, Stefan
    Duan, Xiuzhen
    LABORATORY INVESTIGATION, 2018, 98 : 638 - 638
  • [2] SOX9, a useful Immunohistochemical Marker to Discriminate Hepatocellular Carcinomas from Intrahepatic Cholangiocarcinomas
    Khan, Reema
    Ding, Xianzhong
    Ma, Yihong
    Chen, Hannah
    Pambuccian, Stefan
    Duan, Xiuzhen
    MODERN PATHOLOGY, 2018, 31 : 638 - 638
  • [3] Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma
    Matsushima, Hajime
    Kuroki, Tamotsu
    Kitasato, Amane
    Adachi, Tomohiko
    Tanaka, Takayuki
    Hirabaru, Masataka
    Hirayama, Takanori
    Kuroshima, Naoki
    Hidaka, Masaaki
    Soyama, Akihiko
    Takatsuki, Mitsuhisa
    Kinoshita, Naoe
    Sano, Kazunori
    Nishida, Noriyuki
    Eguchi, Susumu
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (12) : 1067 - 1075
  • [4] Context-Dependent Distinct Roles of SOX9 in Combined Hepatocellular Carcinoma-Cholangiocarcinoma
    Park, Yoojeong
    Hu, Shikai
    Kim, Minwook
    Oertel, Michael
    Singhi, Aatur
    Monga, Satdarshan P.
    Liu, Silvia
    Ko, Sungjin
    CELLS, 2024, 13 (17)
  • [5] SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance
    Xiaodong Yuan
    Jun Li
    Cédric Coulouarn
    Tao Lin
    Laurent Sulpice
    Damien Bergeat
    Carolina De La Torre
    Roman Liebe
    Norbert Gretz
    Matthias P. A. Ebert
    Steven Dooley
    Hong-Lei Weng
    British Journal of Cancer, 2018, 119 : 1358 - 1366
  • [6] SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance
    Yuan, Xiaodong
    Li, Jun
    Coulouarn, Cedric
    Lin, Tao
    Sulpice, Laurent
    Bergeat, Damien
    De la Torre, Carolina
    Liebe, Roman
    Gretz, Norbert
    Ebert, Matthias P. A.
    Dooley, Steven
    Weng, Hong-Lei
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 1358 - 1366
  • [7] SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma
    Takayuki Kawai
    Kentaro Yasuchika
    Takamichi Ishii
    Yuya Miyauchi
    Hidenobu Kojima
    Ryoya Yamaoka
    Hokahiro Katayama
    Elena Yukie Yoshitoshi
    Satoshi Ogiso
    Sadahiko Kita
    Katsutaro Yasuda
    Ken Fukumitsu
    Junji Komori
    Etsuro Hatano
    Yoshiya Kawaguchi
    Shinji Uemoto
    Scientific Reports, 6
  • [8] SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma
    Kawai, Takayuki
    Yasuchika, Kentaro
    Ishii, Takamichi
    Miyauchi, Yuya
    Kojima, Hidenobu
    Yamaoka, Ryoya
    Katayama, Hokahiro
    Yoshitoshi, Elena Yukie
    Ogiso, Satoshi
    Kita, Sadahiko
    Yasuda, Katsutaro
    Fukumitsu, Ken
    Komori, Junji
    Hatano, Etsuro
    Kawaguchi, Yoshiya
    Uemoto, Shinji
    SCIENTIFIC REPORTS, 2016, 6
  • [9] SOX9 IS A NOVEL CANCER STEM CELL MARKER SURROGATED BY OSTEOPONTIN IN HUMAN HEPATOCELLULAR CARCINOMA
    Kawai, T.
    Yasuchika, K.
    Ishii, T.
    Katayama, H.
    Yoshitoshi, E. Y.
    Ogiso, S.
    Kita, S.
    Yasuda, K.
    Fukumitsu, K.
    Mizumoto, M.
    Hatano, E.
    Kawaguchi, Y.
    Uemoto, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S217 - S217
  • [10] Serum N-glycan fingerprint helps to discriminate intrahepatic cholangiocarcinoma from hepatocellular carcinoma
    Huang, Chenjun
    Xu, Xuewen
    Wang, Mengmeng
    Xiao, Xiao
    Cheng, Cheng
    Ji, Jun
    Fang, Meng
    Gao, Chunfang
    ELECTROPHORESIS, 2021, 42 (11) : 1187 - 1195